Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia

World Journal of Urology

Volumn 28, Issue 3, 2010, Pages 379-383

  Oreste, Martella ^a,b   Giuseppe, Paradiso Galatioto ^a,b   Gianna, Pace ^a,b   Adriano, Angelucci ^a,b   Stefano, Necozione ^a,b   Mauro, Bologna ^a,b   Carlo, Vicentini ^a,b  

^a G Mazzini Hospital   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Morphometry; Prostatic volume; PSA; TZ biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOMA; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; EPITHELIUM; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROBABILITY; PROSTATE HYPERTROPHY; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOMA; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COHORT STUDIES; EPITHELIUM; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROBABILITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77952881057     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0465-2     Document Type: Article

References (23)

1. Oesterling JE (1995) Prostate specific antigen. Its role in the diagnosis and staging of prostate cancer. Cancer 75: 1795-1804.
2. Partin AW, Oesterling JE (1994) The clinical usefulness of prostate specific antigen: update 1994. J Urol 152(55): 1358-1368 (Review).
3. Lloyd SN, Collins GN, McKelvie GB, Hehir M, Rogers ACN (1994) Predicted and actual change in serum PSA following prostatectomy for BPH. Urology 43: 472-479.
4. Babaian RJ, Miyashita H, Evans RB, Ramirez EI (1992) The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age. J Urol 147: 837-840.
5. Hammerer PG, McNeal JE, Stamey TA (1995) Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol 153(1): 111-114.
6. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916.
7. Graves HC, Wehner N, Stamey TA (1990) Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard. J Urol 144: 1516-1522.
8. Lepor H, Wang B, Shapiro E (1994) Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology 44: 199-205.
9. Papsidero LD, Kuriyama M, Wang MC, Horoszewicz J, Leong SS, Valenzuela L et al (1981) Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst 66: 37-42.
10. Shapiro E, Hartanto V, Lepor H (1992) The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate 21(4): 297-307.
11. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH (1992) The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 147(3 Pt 2): 817-821.
12. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH (1992) Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147(3 Pt 2): 815-816.
13. Bazinet M, Meshref AW, Trudel C, Aronson S, Péloquin F, Nachabe M, Bégin LR, Elhilali MM (1994) Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology 43(1): 44-51 (discussion 51-52).
14. Kalish J, Cooner WH, Graham SD Jr (1994) Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 43(5): 601-606.
15. Zlotta AR, Djavan B, Marberger M et al (1997) Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol 157(4): 1315-1321.
16. Ohigashi T, Kanao K, Kikuchi E, Nakagawa K, Nakashima J, Marumo K et al (2005) Prostate specific antigen adjusted for transition zone epithelial volume: the powerful predictor for the detection of prostate cancer on repeat biopsy. J Urol 173: 1541-1545.
17. Cadeddu JA, Pearson JD, Lee BR, Landis P, Partin AW, Epstein JI et al (1995) Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia. Urology 45: 795-800.
18. Zlotta A, Sattar AA, Wespes E, Noel JC, Schulman CC (1996) Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study. Urology 47: 329-334.
19. Fukatsu A, Ono Y, Ito M, Yoshino Y, Hattori R, Gotoh M et al (2003) Relationship between serum prostate-specific antigen and calculated epithelial volume. Urology 61: 370-374.
20. McNeal J, Noldus J (1996) Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia. Urology 48(5): 751-756.
21. Marks LS, Treiger B, Dorey FJ, Fu YS, deKernion JB (1994) Morphometry of the prostate: distribution of tissue components in hyperplastic glands. Urology 44(4): 486-492.
22. Robert M, Costa P, Bressolle F, Mottet N, Navatril H (1995) Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens. Br J Urol 75: 317-324.
23. Puppo P (2007) Repeated negative prostate biopsies with persistently elevated or rising PSA: a modern urologic dilemma. Eur Urol 52(3): 639-641.